Literature DB >> 11343734

Understanding the experience of pain in terminally ill patients.

S C Weiss1, L L Emanuel, D L Fairclough, E J Emanuel.   

Abstract

BACKGROUND: Terminally ill patients commonly experience substantial pain. Unresolved pain has been cited as evidence that end-of-life care is of poor quality. However, the data on which that conclusion is based are limited. We aimed to provide additional data on the experience of pain in such patients.
METHODS: We interviewed 988 terminally ill patients from six randomly selected US sites. We asked them who had treated their pain in the previous 4 weeks (primary-care physician, pain specialist, or both), and whether they wanted more pain medication than they were receiving, or why they did not want more.
FINDINGS: 496 (50%) terminally ill patients reported moderate or severe pain. 514 (52%) individuals had seen a primary-care physician for treatment of pain in the previous 4 weeks and 198 (20%) saw a pain specialist. Of those who had been treated by their primary-care physician, 287 (29%) wanted more therapy, 613 (62%) wanted their pain therapy to remain the same, and 89 (9%) wanted to reduce or stop their pain therapy. Several reasons for not wanting additional therapy were offered-fear of addiction, dislike of mental or physical side-effects, and not wanting to take more pills or injections. We saw no association between disease and amount of pain between disease and the desire for more treatment. Black patients were more likely to seek additional pain therapy, see a pain specialist, and refuse additional medication because of fear of addiction than other populations.
INTERPRETATION: Although half of terminally ill patients experienced moderate to severe pain, only 30% of them wanted additional pain treatment from their primary-care physician. The number of patients experiencing pain remains too high. However, the number is not as large as perceived. Additionally, most are willing to tolerate pain. Furthermore, the experience of pain is constant across major terminal diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343734     DOI: 10.1016/S0140-6736(00)04515-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Multiprofessional team approach in palliative care units in Japan.

Authors:  Etsuko Maeyama; Masako Kawa; Mitsunori Miyashita; Taketoshi Ozawa; Noriko Futami; Yuriko Nakagami; Chieko Sugishita; Keiko Kazuma
Journal:  Support Care Cancer       Date:  2003-04-17       Impact factor: 3.603

2.  Enhancing communication between oncologists and patients with a computer-based training program: a randomized trial.

Authors:  James A Tulsky; Robert M Arnold; Stewart C Alexander; Maren K Olsen; Amy S Jeffreys; Keri L Rodriguez; Celette Sugg Skinner; David Farrell; Amy P Abernethy; Kathryn I Pollak
Journal:  Ann Intern Med       Date:  2011-11-01       Impact factor: 25.391

3.  Cancer pain for the 21st century: stepping off the ladder, stepping up to new challenges.

Authors:  Sam H Ahmedzai
Journal:  Br J Pain       Date:  2014-11

4.  Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain.

Authors:  Benjamin Storek; Matthias Reinhardt; Cheng Wang; William G M Janssen; Nina M Harder; Michaela S Banck; John H Morrison; Andreas S Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

5.  The epidemiology of pain during the last 2 years of life.

Authors:  Alexander K Smith; Irena Stijacic Cenzer; Sara J Knight; Kathleen A Puntillo; Eric Widera; Brie A Williams; W John Boscardin; Kenneth E Covinsky
Journal:  Ann Intern Med       Date:  2010-11-02       Impact factor: 25.391

6.  Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer.

Authors:  Soko Setoguchi; Robert J Glynn; Margaret Stedman; Carol M Flavell; Raisa Levin; Lynne Warner Stevenson
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

7.  What are cancer patients' preferences about treatment at the end of life, and who should start talking about it? A comparison with healthy people and medical staff.

Authors:  S Sahm; R Will; G Hommel
Journal:  Support Care Cancer       Date:  2005-01-19       Impact factor: 3.603

Review 8.  Palliative care for end-stage heart failure.

Authors:  Sarah J Goodlin
Journal:  Curr Heart Fail Rep       Date:  2005-09

9.  Characteristics and outcomes of advanced cancer patients who miss outpatient supportive care consult appointments.

Authors:  Marvin Omar Delgado Guay; Marvin Omar Delgado Guay; Silvia Tanzi; Maria Teresa San Miguel Arregui; Maria Teresa San Miguel Arregui; Gary Chisholm; Maxine G De la Cruz; Maxine de la Cruz; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2014-04-26       Impact factor: 3.603

10.  Histopathology and biochemistry analysis of the interaction between sunitinib and paracetamol in mice.

Authors:  Adeline Yl Lim; Ignacio Segarra; Srikumar Chakravarthi; Sufyan Akram; John P Judson
Journal:  BMC Pharmacol       Date:  2010-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.